Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier

Int J Mol Sci. 2019 Jan 14;20(2):315. doi: 10.3390/ijms20020315.

Abstract

Cyclodextrins (CDs) have beneficial characteristics for drug delivery, including hydrophobic interior surfaces. Nanocarriers with β-CD ligands have been prepared with simple surface modifications as drug delivery vehicles. In this study, we synthesized β-CD derivatives on an Ag-embedded silica nanoparticle (NP) (SiO₂@Ag NP) structure to load and release doxorubicin (DOX). Cysteinyl-β-CD and ethylenediamine-β-CD (EDA-β-CD) were immobilized on the surface of SiO₂@Ag NPs, as confirmed by transmission electron microscopy (TEM), ultraviolet-visible (UV-Vis) spectrophotometry, and Fourier transform infrared (FTIR) spectroscopy. DOX was introduced into the β-CD on the SiO₂@Ag NPs and then successfully released. Neither cysteinyl-β-CD and EDA-β-CD showed cytotoxicity, while DOX-loaded cysteinyl-β-CD and EDA-β-CD showed a significant decrease in cell viability in cancer cells. The SiO₂@Ag NPs with β-CD provide a strategy for designing a nanocarrier that can deliver a drug with controlled release from modified chemical types.

Keywords: cyclodextrin; doxorubicin (DOX); drug delivery.

MeSH terms

  • Breast Neoplasms / drug therapy
  • Cell Survival / drug effects
  • Doxorubicin / chemistry
  • Drug Carriers / administration & dosage
  • Drug Carriers / chemistry*
  • Drug Delivery Systems*
  • Female
  • Humans
  • MCF-7 Cells
  • Microscopy, Electron, Transmission
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Silicon Dioxide / administration & dosage
  • Silicon Dioxide / chemistry
  • Silver / chemistry
  • Spectroscopy, Fourier Transform Infrared
  • beta-Cyclodextrins / administration & dosage
  • beta-Cyclodextrins / chemistry*

Substances

  • Drug Carriers
  • beta-Cyclodextrins
  • Silver
  • Silicon Dioxide
  • Doxorubicin
  • betadex